Skip to main content
. Author manuscript; available in PMC: 2015 Jun 25.
Published in final edited form as: Neurocrit Care. 2013 Aug;19(1):31–40. doi: 10.1007/s12028-012-9706-0

Table 3.

MRI lesions in subjects by those treated with hypothermia therapy or normothermia

Region, n (%) T1 T2 DWI/ADC
NT
(n=9)
HT
(n=18)
P-value NT
(n=9)
HT
(n=18)
P-value NT
(n=7)
HT
(n=17)
P-value

Brain lobes 2 (22) 4 (21) 1.00 5 (56) 5 (28) .22 3 (43) 6 (35) 1.00
 Temporal 1 (11) 1 (6) 1.00 2 (22) 3 (18) 1.00 1 (14) 4 (25) 1.00
 Frontal 2 (22) 1 (6) .25 4 (44) 4 (24) .38 3 (43) 4 (25) .63
 Occipital 1 (11) 3 (16) 1.000 3 (33) 5 (29) 1.00 3 (43) 6 (38) 1.00
 Parietal 1 (11) 2 (11) 1.00 4 (44) 5 (29) .67 2 (29) 6 (40) 1.00
 Insular 0 (0) 0 (0) 1.00 1 (11) 2 (12) 1.00 1 (14) 0 (0) .30

Basal ganglia 2 (22) 2 (11) .57 2 (22) 8 (44) .41 1 (14) 3 (18) 1.00
 Lenticular 2 (22) 2 (11) .58 2 (22) 7 (41) .42 1 (14) 3 (19) 1.00
 Caudate 1 (11) 0 (0) .33 2 (22) 5 (29) 1.00 1 (14) 1 (6) .53

Thalamus 1 (11) 0 (0) .32 1 (11) 4 (22) .64 1 (14) 0 (0) .29

Cerebellum 1 (11) 0 (0) .32 1 (11) 0 (0) .33 2 (29) 0 (0) .08

Brainstem 1 (11) 0 (0) .32 2 (22) 2 (11) .58 1 (14) 0 (0) .29

Generalized edema 1 (11) 1 (5) 1.00 1 (11) 1 (6) 1.00 1 (14) 1 (6) .51

HT, hypothermia; NT, normothermia